IFNG and schizophrenia: Further clinical studies have found increased biomarkers of neuroinflammation in schizophrenia patients, including greater levels of circulating inflammatory cytokines such as Interleukin-6 (IL-6), Tumour Necrosis Factor Alpha (TNF-α) and Interferon Gamma (IFN-γ) (35, 173–176).